Aprea Therapeutics Operating Margin Growth & History (APRE)

Aprea Therapeutics's operating margin was −4,631.12% for fiscal 2025.

View full Aprea Therapeutics company overview

Aprea Therapeutics annual operating margin history

Aprea Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−4,631.12%−3678.11 pp
20242024-12-31−953.00%+1699.80 pp
20232023-12-31−2,652.80%

Aprea Therapeutics operating margin trends

Between the periods ended 2023-12-31 and 2025-12-31, Aprea Therapeutics's operating margin decreased from −2,652.80% to −4,631.12%, a change of −1978.32 percentage points. The latest reported quarter, Q4 2025, shows −79,205.66%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Aprea Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about APRE yet. Start the conversation.

Write the first post